Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin
Unknown
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if one regimen will require patients to spend more time in the hospital than the other regimen for treatment of chemotherapy-related side effects. PURPOSE: Randomized phase III trial to compare the hospitalization rates of patients who are receiving gemcitabine combined with cisplatin with that of pati... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/19/2013
Locations: Christie Hospital NHS Trust, Manchester, England
Conditions: Lung Cancer
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
Unknown
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy after chemotherapy may kill any remaining tumor cells. PURPOSE: This phase II trial is studying how well giving combination chemotherapy together with or without radiation... Read More
Gender:
ALL
Ages:
3 years and below
Trial Updated:
09/19/2013
Locations: Our Lady's Hospital for Sick Children, Dublin, Not set +20 locations
Conditions: Brain and Central Nervous System Tumors, Neuroblastoma
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
Active Not Recruiting
RATIONALE: Gathering information about how young patients with ependymoma respond to standard combination chemotherapy and learning about the long-term effects of this treatment may help doctors plan better treatment. PURPOSE: This phase III trial is observing young patients with ependymoma undergoing standard combination chemotherapy.
Gender:
ALL
Ages:
2 years and below
Trial Updated:
09/19/2013
Locations: Birmingham Children's Hospital, Birmingham, England +9 locations
Conditions: Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Long-term Effects Secondary to Cancer Therapy in Children, Ototoxicity
Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
Unknown
RATIONALE: Sometimes, after surgery, the tumor may not need additional treatment until it progresses. In this case, observation may be sufficient. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving combination chemotherapy after surgery may kill any remaining tumor cells. PURPOSE: This phase III trial is studying... Read More
Gender:
ALL
Ages:
17 years and below
Trial Updated:
09/16/2013
Locations: Our Lady's Hospital for Sick Children Crumlin, Dublin, Not set +19 locations
Conditions: Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
Unknown
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as lomustine, vincristine, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving radiation therapy together with combination chemotherapy after surgery may kill any tumor cells that remain. PURPOSE: This phase II trial is studying giving radiation therapy together with combination chemotherapy to see h... Read More
Gender:
ALL
Ages:
Between 3 years and 21 years
Trial Updated:
09/16/2013
Locations: Our Lady's Hospital for Sick Children Crumlin, Dublin, Not set +21 locations
Conditions: Brain and Central Nervous System Tumors
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
Unknown
RATIONALE: Drugs used in chemotherapy, such as cisplatin and doxorubicin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Thalidomide may stop the growth of liver cancer by blocking blood flow to the tumor. Chemoembolization kills tumor cells by blocking the blood flow to the tumor and keeping chemotherapy drugs near the tumor. Giving combinatio... Read More
Gender:
ALL
Ages:
29 years and below
Trial Updated:
09/16/2013
Locations: Our Lady's Hospital for Sick Children Crumlin, Dublin, Not set +20 locations
Conditions: Liver Cancer
Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma
Unknown
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy after surgery may kill any tumor c... Read More
Gender:
ALL
Ages:
1 year and above
Trial Updated:
09/16/2013
Locations: Our Lady's Hospital for Sick Children, Dublin, Not set +21 locations
Conditions: Neuroblastoma
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
Unknown
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving chemotherapy and radiation therapy after surgery may kill any tumor cells that remain after surgery. Sometimes, the tumor may not ne... Read More
Gender:
ALL
Ages:
1 year and below
Trial Updated:
09/16/2013
Locations: Our Lady's Hospital for Sick Children, Dublin, Not set +21 locations
Conditions: Neuroblastoma
Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain
Completed
RATIONALE: Drugs used in chemotherapy, such as carboplatin, etoposide, ifosfamide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving more than one drug (combination chemotherapy) with radiation therapy may kill more tumor cells. PURPOSE: This phase III trial is studying combination chemotherapy followed by radiation therapy to see how well i... Read More
Gender:
ALL
Ages:
All
Trial Updated:
09/16/2013
Locations: Our Lady's Hospital for Sick Children, Dublin, Not set +20 locations
Conditions: Brain and Central Nervous System Tumors
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
Unknown
RATIONALE: Drugs used in chemotherapy, such as cisplatin and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving cisplatin together with temozolomide works in treating young patients with malignant glioma.
Gender:
ALL
Ages:
Between 4 years and 20 years
Trial Updated:
09/16/2013
Locations: Institut Gustave Roussy, Villejuif, Not set +22 locations
Conditions: Brain and Central Nervous System Tumors
A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Completed
The purpose of this trial is to estimate progression free survival in patients with recurrent or metastatic head and neck cancer that have not received chemotherapy in this setting.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/05/2013
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Edegem, Not set +12 locations
Conditions: Head and Neck Neoplasms
Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
Completed
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with radiation therapy may kill more tumor cells. It is not yet known if fluorouracil plus radiation therapy is more effective with or without additional chemotherapy in treating anal cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of fluorouracil plus radiation thera... Read More
Gender:
ALL
Ages:
All
Trial Updated:
08/23/2013
Locations: Northwick Park Hospital, Harrow, England +12 locations
Conditions: Anal Cancer